HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating oncomiRs

Cancer Research

Volumn 74, Issue 21, 2014, Pages 6082-6093

  Vernin, Céline ^a   Thenoz, Morgan ^a   Pinatel, Christiane ^b   Gessain, Antoine ^c   Gout, Olivier ^d   Delfau Larue, Marie Hélène ^e   Nazaret, Nicolas ^a   Legras Lachuer, Catherine ^a   Wattel, Eric ^a   Mortreux, Franck ^a  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c INSTITUT PASTEUR   (France)

^d FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 17; MICRORNA 21; PROTEIN HBZ; UNCLASSIFIED DRUG; VIRUS PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOWN REGULATION; FEMALE; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OBFC2A GENE; PROTEIN FUNCTION; RETROVIRUS INFECTION; RNA TRANSLATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; METABOLISM; PATHOLOGY; REGULATOR GENE; T CELL LEUKEMIA;

ADULT; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GENE EXPRESSION REGULATION, VIRAL; GENES, PX; GENOMIC INSTABILITY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; VIRAL PROTEINS;

EID: 84909996043     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3564     Document Type: Article

References (62)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
3. Nakao K, Ohba N, Matsumoto M. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 1989;33:472-81.
4. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection [see comments]. Lancet 1990;336:1345-7.
5. Zane L, Sibon D, Mortreux F, Wattel E. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci 2009;14:3935-41.
6. Sibon D, Gabet AS, Zandecki M, Pinatel C, Thete J, Delfau-Larue MH, et al. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest 2006;116:974-83.
7. + T cells. Int J Cancer 2012;131:821-33.
8. + cells relies on cIAP-2 but not on c-FLIP expression. Virology 2010;407:341-51.
9. de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F. Gene expression array of HTLV type 1-infected T cells: up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses 2000;16:1695-700.
10. Lairmore MD, Haines R, Anupam R. Mechanisms of human T-lymphotropic virus type 1 transmission and disease. Curr Opin Virol 2012;2:474-81.
11. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, WillemsL. The HTLV-1 Tax interactome. Retrovirology 2008;5:76.
12. Currer R, Van Duyne R, Jaworski E, Guendel I, Sampey G, Das R, et al. HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Front Microbiol 2012;3:406.
13. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007;7:270-80.
14. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004;109:559-67.
15. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996;88:3065-73.
16. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, et al. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005;2:64.
17. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor genemRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 2006;103:720-5.
18. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002;76:12813-22.
19. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008;112:3788-97.
20. Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, et al. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009;6:19.
21. Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 2011;7:e1001274.
22. Itoyama T, Chaganti RS, Yamada Y, Tsukasaki K, Atogami S, Nakamura H, et al. Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. Blood 2001;97:3612-20.
23. Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003;17:26-38.
24. Mortreux F, Leclercq I, Gabet AS, Leroy A, Westhof E, Gessain A, et al. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst 2001;93:367-77.
25. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
26. Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle 2009;8:1473-7.
27. Roberts AP, Lewis AP, Jopling CL. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 2011;39:7716-29.
28. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-4.
29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
30. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012;21:121-35.
31. Tomita M, Tanaka Y, Mori N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer 2012;130:2300-9.
32. Pichler K, Schneider G, Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 2008;5:100.
33. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008;68:8976-85.
34. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-14.
35. + T cells by the microRNA miR-125b. Nat Immunol 2011;12:796-803.
36. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32.
37. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-58.
38. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 2010;107:21098-103.
39. Walter BA, Gomez-Macias G, Valera VA, Sobel M, Merino MJ. miR-21 expression in pregnancy-associated breast cancer: a possible marker of poor prognosis. J Cancer 2011;2:67-75.
40. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol 2004;339:327-35.
41. Broderick S, Rehmet K, Concannon C, Nasheuer HP. Eukaryotic single-stranded DNA binding proteins: central factors in genome stability. Subcell Biochem 2010;50:143-63.
42. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010;17:215-20.
43. Zhao T, Matsuoka M. HBZ and its roles in HTLV-1 oncogenesis. Front Microbiol 2012;3:247.
44. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007;129:147-61.
45. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007;316:608-11.
46. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010;33:607-19.
47. Rahman S, Quann K, Pandya D, Singh S, Khan ZK, Jain P. HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS ONE 2012;7:e34490.
48. Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, et al. Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med 2010;31:367-82.
49. Van Duyne R, Guendel I, Klase Z, Narayanan A, Coley W, Jaworski E, et al. Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery. PLoS ONE 2012;7:e40662.
50. Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of micro-RNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009;113:4914-7.
51. Jin L, Wessely O, Marcusson E, Ivan C, Calin G, Alahari SK. Prooncogenic factors miR-23b-and miR-27b are regulated by Her2/Neu, EGF, and TNFalpha in breast cancer. Cancer Res 2013;73:2884-96.
52. Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012;18:1077-86.
53. Lee JJ, Drakaki A, Iliopoulos D, Struhl K. MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene 2012;31:3818-25.
54. Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009;284:23094-106.
55. Feldhahn N, Ferretti E, Robbiani DF, Callen E, Deroubaix S, Selleri L, et al. The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo. EMBO J 2012;31:4045-56.
56. Li Y, Bolderson E, Kumar R, Muniandy PA, Xue Y, Richard DJ, et al. HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. J Biol Chem 2009;284:23525-31.
57. Tsukasaki K. Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis. J Clin Immunol 2002;22:57-63.
58. Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR, et al. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 2001;97:3875-81.
59. Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T, et al. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood 1997;89:948-56.
60. Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, et al. Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes. Blood 2011;117:5473-8.
61. Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, Birnbaum D. Myeloid malignancies: mutations, models and management. BMC Cancer 2012;12:304.
62. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10:878-89.